Efficacy of chimeric antigen receptor engineered natural killer cells in the treatment of hematologic malignancies: a systematic review and meta-analysis of preclinical studies
- 22 November 2024
- journal article
- review article
- Published by Elsevier in Cytotherapy
- Vol. 27 (3) , 350-364
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 64 references indexed in Scilit:
- A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumorsMed, 2023
- Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemiaCancer Letters, 2023
- CCR7 expression in CD19 chimeric antigen receptor-engineered natural killer cells improves migration toward CCL19-expressing lymphoma cells and increases tumor control in mice with human lymphomaCytotherapy, 2022
- Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studiesCytotherapy, 2022
- Irradiated chimeric antigen receptor engineered NK-92MI cells show effective cytotoxicity against CD19+ malignancy in a mouse modelCytotherapy, 2020
- Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growthInternational Journal of Cancer, 2019
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor ActivityCell Stem Cell, 2018
- Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphomaCytotherapy, 2017
- Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cellsMolecular Oncology, 2013
- Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cellsCancer Immunology, Immunotherapy, 2007